Maxim Doubles Price Target on Athersys (ATHX)
Tweet
Share
E-mailGet Alerts ATHX Hot Sheet
Price: $0.10 --0%
Rating Summary:
4 Buy, 1 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 14 | Down: 24 | New: 9
Rating Summary:
4 Buy, 1 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 14 | Down: 24 | New: 9
Join SI Premium – FREE
Maxim Group boosted its price target on Athersys (NASDAQ: ATHX) today from $3 to $6 while maintaining a Buy rating, which follows positive preclinical study results showing that stem cell treatment could help MS patients.
For an analyst ratings summary and ratings history on Athersys click here. For more ratings news on Athersys click here.
Shares of Athersys are up 3.8 percent following.
For an analyst ratings summary and ratings history on Athersys click here. For more ratings news on Athersys click here.
Shares of Athersys are up 3.8 percent following.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Sun Pharmaceutical Industries Ltd. (SUNP:IN) PT Raised to INR2,238 at Elara Securities India
- Global Health Limited (MEDANTA:IN) PT Raised to INR1,660 at Jefferies
- Macquarie Downgrades Roblox Corp. (RBLX) to Neutral
Create E-mail Alert Related Categories
Analyst Comments, Analyst PT ChangeRelated Entities
Maxim GroupSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
